Literature DB >> 33175122

The Influence of Disease Activity on Pregnancy Outcomes in Women With Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis.

Min-A Kim1, Young-Han Kim2, Jaeyoung Chun3, Hye Sun Lee4, Soo Jung Park5, Jae Hee Cheon5, Tae Il Kim5, Won Ho Kim5, Jae Jun Park5.   

Abstract

BACKGROUND AND AIMS: Robust evidence regarding the impact of disease activity on pregnancy outcomes in women with inflammatory bowel disease [IBD] is crucial for both clinicians and patients in preparing a birth plan. We sought to perform a systematic review and meta-analysis to assess the pooled influences of disease activity on pregnancy outcomes in women with IBD.
METHODS: We searched MEDLINE, EMBASE and the COCHRANE library to identify articles comparing pregnancy outcomes between active and inactive IBD at the time of conception or during pregnancy. A meta-analysis was performed using a random-effects model to pool estimates and report odds ratios [ORs].
RESULTS: A total of 28 studies were identified as eligible for the meta-analysis. In women with active IBD, the pooled ORs for low birth weight [LBW], preterm birth, small for gestational age [SGA], spontaneous abortion and stillbirths were respectively 3.81 (95% confidence interval [CI] 1.81-8.02), 2.42 [95% CI 1.74-3.35], 1.48 [95% CI 1.19-1.85], 1.87 [95% CI 1.17-3.0] and 2.27 [95% CI 1.03-5.04] compared to women with inactive IBD. In the subgroup analysis based on disease type, women with active ulcerative colitis had an increased risk of LBW, preterm birth and spontaneous abortion. Women with active Crohn's disease had a higher risk of preterm birth, SGA and spontaneous abortion.
CONCLUSIONS: Active IBD during the periconception period and pregnancy is associated with an increased risk of adverse pregnancy outcomes. Our data suggest that pregnancy should be planned when the disease is quiescent, and continuous disease control is important even during pregnancy.
© The Author(s) 2020. Published by Oxford University Press on behalf of European Crohn’s and Colitis Organisation. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  Inflammatory bowel disease; disease activity; pregnancy outcome

Year:  2021        PMID: 33175122     DOI: 10.1093/ecco-jcc/jjaa225

Source DB:  PubMed          Journal:  J Crohns Colitis        ISSN: 1873-9946            Impact factor:   9.071


  3 in total

1.  Ovarian reserve and IVF outcomes in patients with inflammatory bowel disease: A systematic review and meta-analysis.

Authors:  Honghao Sun; Jiao Jiao; Feng Tian; Qing Liu; Jiansu Bian; Rongmin Xu; Da Li; Xiuxia Wang; Hong Shu
Journal:  EClinicalMedicine       Date:  2022-07-01

2.  Composition and Stability of the Vaginal Microbiota of Pregnant Women With Inflammatory Bowel Disease.

Authors:  Janet E Hill; Juan-Nicolás Peña-Sánchez; Champika Fernando; Aline C Freitas; Niradha Withana Gamage; Sharyle Fowler
Journal:  Inflamm Bowel Dis       Date:  2022-06-03       Impact factor: 7.290

3.  Care of Women with Chronic Inflammatory Bowel Disease (Chronic IBD) During Pregnancy: Recommendations of the Obstetrics and Prenatal Medicine Working Group of the DGGG.

Authors:  Markus Schmidt; Maritta Kühnert; Bettina Kuschel; Sven Kehl; Ute Margaretha Schäfer-Graf
Journal:  Geburtshilfe Frauenheilkd       Date:  2021-12-08       Impact factor: 2.915

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.